Home Ocular Therapeutix

Ocular Therapeutix

In operation
Post-IPO Round
Ophthalmic Biopharmaceuticals Developer

Basic Information

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for ocular diseases and conditions using its proprietary bioresorbable hydrogel formulation technology, Elutyx™. Ocular Therapeutix has established a robust pipeline of drug delivery solutions designed to reduce the complexity and burden of current standard care and position itself as a leader in the ophthalmology field.
Ocular Therapeutix, Inc.
Bedford,Massachusetts,United States of America
51~100 people
January 01, 2006
info@ocutx.com